Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Damon Runyon identifies scientists with the highest potential to revolutionize how we prevent, diagnose, and treat all forms of cancer.
Ishmeal and Gloria Boles have put their lives back together after his
devastating lung cancer diagnosis.
Racism and bias are not relics of a less enlightened past, but living, active forces that hold us back from scientific breakthroughs.
Damon Runyon-Rachleff Innovator Rushika M. Perera, PhD, and colleagues may have found an answer.
This brings the total number of Damon Runyon scientists who are members of the National Academy of Sciences to 86.
Scientists discuss the challenges of doing research during the COVID-19 pandemic
More than 50 cancers could be discovered, even before symptoms develop.
Oncologist Aaron D. Viny, MD, shares how he’s been treating cancer patients during COVID-19 via Twitter
Scientists are investigating how this new coronavirus enters human cells, developing more efficient testing and searching for a treatment.
An excerpt from an opinion piece about the spread of COVID-19
Glucosinolates, the same small molecules that give broccoli its flavor, have also been associated with decreased risk of certain cancers.
Please help flatten the curve of this pandemic and lessen its impact on healthcare workers and at-risk individuals.
The study helps explain how cancer cells adapt and tolerate treatment and identify combination therapies to improve outcomes in people.
This may be catalytic for his research on the development of novel cancer therapies.
This is the decade to double down on our investment in research, to focus on the next-generation breakthroughs that will save more lives.
Understanding how these drugs kill cancer cells provides new insights into how to defeat this complex disease.
This support helps foster the next generation of brave and bold scientists and fill gaps in traditional research funding.
The award funds cancer research by exceptionally creative thinkers with “high-risk/high-reward” ideas.
Research offers hope that drugs given before metastasis could reduce the number of patients who progress to Stage IV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.